Partnering is an important element of Medivir’s business strategy.

Out-licensing of Medivir R&D pipeline projects

Together with our partners we have been successful in taking two products from research, through clinical development to launch on a global scale. At selected development stages we seek to out-license our R&D pipeline projects to suitable companies to ensure continued, efficient development and commercialization. Companies with a potential interest in our pipeline projects are invited to register interest and to discuss partnering opportunities.

In-licensing / research collaboration of partner projects

Medivir maintains a robust pipeline of R&D projects supported by a track record of in-licensing and research collaborations with academic institutions, biotechs and larger pharmaceutical companies. We would very much like to encourage parties with research to early-development stage projects in Medivir’s areas of therapeutic interest to make contact to discuss such partnering opportunities. We are open to different partnership structures to ensure the best possible progress for projects.

Would you like to discuss a partnership opportunity in R&D? Would you like to just discuss our partnering interests in more detail? Please send an e-mail to

Page updated 15 May 2017